LENSAR (LNSR) Stock Price

LENSAR Price

NASDAQ·CLOSED
6.51
​
Market closed

Revenue has compounded at 13.3% per year over the past 7 years to 58.44 M USD. LENSAR's net margin stands at -58.7%, down from -56.9% several years earlier. Analysts set a median price target of 11.50 USD, implying 76.7% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

LENSAR stock price

Access this data via the Eulerpool API

LENSAR business model & stock analysis

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 110 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its systems, the LENSAR Laser System and ALLY Adaptive Cataract Treatment System incorporate a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device kit. The company has developed its ALLY Adaptive Cataract Treatment System (ALLY System). The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room.

Frequently asked questions about LENSAR

Analysts currently set an average price target of 11.50 USD for the LENSAR stock (median: 11.50 USD), implying +76.7 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the LENSAR stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect LENSAR to generate revenue of 61.29 M USD and earnings per share of 0.01 USD.

Converted at the current exchange rate, the LENSAR share trades at 5.81 EUR (6.51 USD).

The LENSAR share (LNSR) is listed on 1 stock exchanges, including: NASDAQ (LNSR).

The expected revenue of LENSAR is 61.29 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of LENSAR is 93,132.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of LENSAR is currently 843.84. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LENSAR stock.

The price-to-sales ratio (P/S) of LENSAR is currently 1.28. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LENSAR stock.

The Eulerpool Quality Score for LENSAR is 3/10.

The ISIN of LENSAR is US52634L1089. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of LENSAR is LNSR. The ticker symbol is used to trade LENSAR shares on the stock exchange.

Fair ValueTerminal
6.90 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
389,566.67 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website lensar.com
Currency
USD
Initial public offering
Sep 21, 2020
ISIN
US52634L1089
Cusip
52634L108
Market capitalization
77.73 M USDMicro Cap
52-Week Range
PEG
-0.05
P/E ratio
P/Ee 2026
834.62
P/Ee 2027
-29.48
P/Ee 2028
291.93
P/S
P/Se
1.28
EV/EBIT
—
P/B Ratio
4.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
135.64 %
Last updated Oct 8, 2026, 10:54 PM

LENSAR Peer Group

LENSAR Ticker

NASDAQ · LNSR

LENSAR FIGI

LNSR:US · BBG00X8RZBR7LNSR:UA · BBG00X8RZBS6LNSR:UC · BBG00X8RZBT5LNSR:UN · BBG00X8RZBW1LNSR:UP · BBG00X8RZBX0LNSR:UB · BBG00X8RZBZ8LNSR:UM · BBG00X8RZC13LNSR:UX · BBG00X8RZC22LNSR:UR · BBG00X8RZC31LNSR:UD · BBG00X8RZC77LNSR:UF · BBG00X8RZCB2LNSR:VY · BBG00X8RZCC1

All fundamentals and in-depth analysis of LENSAR

Our stock analysis for LENSAR stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LENSAR. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.